Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Will Leqembi’s primary benefit—a slight slowing of decline in cognition and functioning—make a difference to patients and family members...
Leqembi and related care could cost Medicare up to $5 billion a year, making it one of the most expensive taxpayer-funded treatments.
While patient advocates are celebrating, critics predict the rollout of Leqembi will aggravate racial disparities in elder care.
Alzheimer’s advocates laud the approval of Aduhelm, but experts raise questions about its effectiveness and cost.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.